Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Enterovirus A71 (EV-A71) is a non-enveloped, icosahedral virus belonging to the family Picornaviridae. The viral particle measures approximately 20–30 nm in diameter and contains a single-stranded positive-sense RNA genome. The capsid is composed of VP1, VP2, VP3, and VP4 proteins. VP1 is a major immunodominant protein and key for entry. The virus uses receptors like SCARB2 and PSGL-1 to enter host cells. EV-A71 causes hand, foot, and mouth disease (HFMD) and can lead to severe neurological complications. Inactivated vaccines have been developed, but no specific antiviral drugs are approved.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Enterovirus A71 Viral Particle (EV-A71).